Albendazole and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Albendazole (albendazole), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Stromectol, and have Onchocerciasis.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Albendazole. It is created by eHealthMe based on reports of 1,389 people who have side effects when taking Albendazole from the FDA, and is updated regularly.

What is Albendazole?

Albendazole has active ingredients of albendazole. eHealthMe is studying from 1,394 Albendazole users. Check the latest studies of Albendazole.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,403 drugs and 3,350 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 05, 2026

1,389 people reported to have side effects when taking Albendazole.
Among them, 11 people (0.79%) have Swallowing difficulty.

Could Albendazole cause Swallowing difficulty?

Among these 11 people:

How long have people been on Albendazole when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Albendazole? *

female: 30 %
male: 70 %

What is the age of people who have Swallowing difficulty when taking Albendazole? *

What are other drugs people take besides Albendazole? *

What are other side effects people have besides Swallowing difficulty? *

Fever: 9 people, 81.82%
Pruritus Generalised (generalized itching): 5 people, 45.45%
Rashes (redness): 5 people, 45.45%
Erythema Multiforme (a type of hypersensitivity reaction): 5 people, 45.45%
Headache (pain in head): 5 people, 45.45%
Swallowing Pain Or Burning: 4 people, 36.36%
Generalised Erythema (redness of the skin all over the body): 4 people, 36.36%
Genital Ulceration (ulcers on sex organ): 4 people, 36.36%
Eye Pain: 4 people, 36.36%
Mouth Ulcers: 4 people, 36.36%

What are the existing conditions these people have? *

Onchocerciasis (a parasitic disease caused by the filarial worm): 5 people, 45.45%
Filariasis Lymphatic (the presence of worms in the regional lymphatic vessels like wuchereria bancrofti, brugia malayi, and brugia timori): 3 people, 27.27%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 27.27%
Pain: 2 people, 18.18%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 2 people, 18.18%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 18.18%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 9.09%
Citrobacter Infection (infection by citrobacter (bacteria)): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Albendazole and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Albendazole:

Albendazole (1,394 reports)

Browse all side effects of Albendazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,403 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,350 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albendazole (the active ingredients of Albendazole) and Albendazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.